A detailed history of Sp Asset Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Sp Asset Management holds 2,352 shares of LLY stock, worth $2.19 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,352
Previous 2,345 0.3%
Holding current value
$2.19 Million
Previous $760,000 0.13%
% of portfolio
0.1%
Previous 0.1%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $2,075 - $2,365
7 Added 0.3%
2,352 $761,000
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $2,229 - $2,618
8 Added 0.34%
2,345 $760,000
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $1,877 - $2,333
8 Added 0.34%
2,337 $669,000
Q4 2021

Feb 02, 2022

BUY
$224.85 - $279.04 $2,023 - $2,511
9 Added 0.39%
2,329 $578,000
Q3 2021

Oct 28, 2021

BUY
$221.6 - $272.71 $1,551 - $1,908
7 Added 0.3%
2,320 $581,000
Q2 2021

Jul 28, 2021

BUY
$180.55 - $233.54 $1,624 - $2,101
9 Added 0.39%
2,313 $563,000
Q1 2021

May 05, 2021

BUY
$164.32 - $212.72 $1,643 - $2,127
10 Added 0.44%
2,304 $434,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $1,435 - $1,898
11 Added 0.48%
2,294 $463,000
Q3 2020

Nov 06, 2020

BUY
$146.22 - $169.13 $1,608 - $1,860
11 Added 0.48%
2,283 $332,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $1,500 - $1,805
11 Added 0.49%
2,272 $373,000
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $1,428 - $1,768
12 Added 0.53%
2,261 $314,000
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $1,283 - $1,589
12 Added 0.54%
2,249 $296,000
Q3 2019

Nov 01, 2019

BUY
$106.79 - $116.16 $238,889 - $259,849
2,237 New
2,237 $250,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $245,067 - $286,055
-2,212 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$111.31 - $131.02 $1,224 - $1,441
11 Added 0.5%
2,212 $287,000
Q4 2018

Feb 08, 2019

BUY
$105.9 - $118.64 $1,164 - $1,305
11 Added 0.5%
2,201 $254,000
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $188,033 - $235,008
2,190 New
2,190 $235,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $886B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sp Asset Management Portfolio

Follow Sp Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sp Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Sp Asset Management with notifications on news.